Characterization of hepatitis E-specific cell-mediated immune response using IFN-γ ELISPOT assay

Journal of Immunological Methods

Volumn 328, Issue 1-2, 2007, Pages 152-161

  Shata, M T ^a   Barrett, A ^a   Shire, N J ^a   Abdelwahab, S F ^b   Sobhy, M ^c   Daef, E ^d   El Kamary, S S ^e   Hashem, M ^c,e   Engle, R E ^f   Purcell, R H ^f   Emerson, S U ^f   Strickland, G T ^e   Sherman, K E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Minia University   (Egypt)

^c VACSERA   (Egypt)

^d ASSIUT UNIVERSITY   (Egypt)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cell mediated; Diagnosis; ELISPOT; Hepatitis E; HEV; Immunity

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CHIMPANZEE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; GENOTYPE; HEPATITIS A; HEPATITIS C VIRUS; HEPATITIS E; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROPREVALENCE; T LYMPHOCYTE; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS E; HUMANS; IMMUNITY, CELLULAR; IMMUNOASSAY; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; PAN TROGLODYTES;

HEPATITIS C VIRUS; PAN;

EID: 35548982503     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.08.014     Document Type: Article

References (58)

1. Aggarwal R., Shukla R., Jameel S., Agrawal S., Puri P., Gupta V.K., Patil A.P., and Naik S. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J. Viral Hepatitis 14 4 (2007) 283
2. Alimonti J.B., Kimani J., Matu L., Wachihi C., Kaul R., Plummer F.A., and Fowke K.R. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Immunol. Cell Biol. 84 5 (2006) 482
3. Al-Sherbiny M., Osman A., Mohamed N., Shata M.T., Abdel-Aziz F., Abdel-Hamid M., Abdelwahab S.F., Mikhail N., Stoszek S., Ruggeri L., Folgori A., Nicosia A., Prince A.M., and Strickland G.T. Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am. J. Trop. Med. Hyg. 73 1 (2005) 44
4. Appella E., Padlan E.A., and Hunt D.F. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules. Exs 73 (1995) 105
5. Arankalle V.A., Goverdhan M.K., and Banerjee K. Antibodies against hepatitis E virus in Old World monkeys. J. Viral Hepatitis 1 2 (1994) 125
6. Bryan J.P., Tsarev S.A., Iqbal M., Ticehurst J., Emerson S., Ahmed A., Duncan J., Rafiqui A.R., Malik I.A., Purcell R.H., et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J. Infect. Dis. 170 3 (1994) 517
7. Chen H.Y., Lu Y., Howard T., Anderson D., Fong P.Y., Hu W.P., Chia C.P., and Guan M. Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin m antibodies to hepatitis e virus in human sera. Clin. Diagn. Lab. Immunol. 12 5 (2005) 593
8. Christensen P.B., Engle R.E., Jacobsen S.E., Krarup H.B., Georgsen J., and Purcell R.H. High prevalence of hepatitis E antibodies among Danish prisoners and drug users. J. Med. Virol. 66 1 (2002) 49
9. Clemente-Casares P., Pina S., Buti M., Jardi R., MartIn M., Bofill-Mas S., and Girones R. Hepatitis E virus epidemiology in industrialized countries. Emerg. Infect. Dis. 9 4 (2003) 448
10. Clerici M., and Shearer G.M. Correlates of protection in HIV infection and the progression of HIV infection to AIDS. Immunol. Lett. 51 1-2 (1996) 69
11. Dawson G.J., Chau K.H., Cabal C.M., Yarbough P.O., Reyes G.R., and Mushahwar I.K. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J. Virol. Methods 38 1 (1992) 175
12. Deliyannis G., Jackson D.C., Ede N.J., Zeng W., Hourdakis I., Sakabetis E., and Brown L.E. Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus. J. Virol. 76 9 (2002) 4212
13. Dheda K., Lalvani A., Miller R.F., Scott G., Booth H., Johnson M.A., Zumla A., and Rook G.A. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. Aids 19 17 (2005) 2038
14. Dittmer U., Spring M., Petry H., Nisslein T., Rieckmann P., Luke W., Stahl-Hennig C., Hunsmann G., and Bodemer W. Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV). J. Biotechnol. 44 1-3 (1996) 105
15. Effros R.B. Long-term immunological memory against viruses. Mech. Ageing Dev. 121 1-3 (2000) 161
16. El-Sayed Zaki M., El-Deen Zaghloul M.H., and El Sayed O. Acute sporadic hepatitis E in children: diagnostic relevance of specific immunoglobulin M and immunoglobulin G compared with nested reverse transcriptase PCR. FEMS Immunol. Med. Microbiol. 48 1 (2006) 16
17. Emerson S.U., and Purcell R.H. Hepatitis E virus. Rev. Med. Virol. 13 3 (2003) 145
18. Engle R.E., Yu C., Emerson S.U., Meng X.J., and Purcell R.H. Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J. Clin. Microbiol. 40 12 (2002) 4576
19. Farid A., Al-Sherbiny M., Osman A., Mohamed N., Saad A., Shata M.T., Lee D.H., Prince A.M., and Strickland G.T. Schistosoma infection inhibits cellular immune responses to core HCV peptides. Parasite Immunol. 27 5 (2005) 189
20. Favorov M.O., Fields H.A., Purdy M.A., Yashina T.L., Aleksandrov A.G., Alter M.J., Yarasheva D.M., Bradley D.W., and Margolis H.S. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J. Med. Virol. 36 4 (1992) 246
21. Fix A.D., Abdel-Hamid M., Purcell R.H., Shehata M.H., Abdel-Aziz F., Mikhail N., el Sebai H., Nafeh M., Habib M., Arthur R.R., Emerson S.U., and Strickland G.T. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am. J. Trop. Med. Hyg. 62 4 (2000) 519
22. Fowke K.R., Nagelkerke N.J., Kimani J., Simonsen J.N., Anzala A.O., Bwayo J.J., MacDonald K.S., Ngugi E.N., and Plummer F.A. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348 9038 (1996) 1347
23. Freeman A.J., Ffrench R.A., Post J.J., Harvey C.E., Gilmour S.J., White P.A., Marinos G., Van Beek I., Rawlinson W.D., and Lloyd A.R. Prevalence of production of virus-specific interferon- gamma among seronegative hepatitis C-resistant subjects reporting injection drug use. J. Infect. Dis. 190 6 (2004) 1093
24. Fukuda S., Sunaga J., Saito N., Fujimura K., Itoh Y., Sasaki M., Tsuda F., Takahashi M., Nishizawa T., and Okamoto H. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus. J. Med. Virol. 73 4 (2004) 554
25. Ghabrah T.M., Tsarev S., Yarbough P.O., Emerson S.U., Strickland G.T., and Purcell R.H. Comparison of tests for antibody to hepatitis E virus. J. Med. Virol. 55 2 (1998) 134
26. Goldsmith R., Yarbough P.O., Reyes G.R., Fry K.E., Gabor K.A., Kamel M., Zakaria S., Amer S., and Gaffar Y. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 339 8789 (1992) 328
27. Guimond M., Fry T.J., and Mackall C.L. Cytokine signals in T-cell homeostasis. J. Immunother. 28 4 (2005) 289
28. Halbur P.G., Kasorndorkbua C., Gilbert C., Guenette D., Potters M.B., Purcell R.H., Emerson S.U., Toth T.E., and Meng X.J. Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J. Clin. Microbiol. 39 3 (2001) 918
29. Hammarlund E., Lewis M.W., Hansen S.G., Strelow L.I., Nelson J.A., Sexton G.J., Hanifin J.M., and Slifka M.K. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9 9 (2003) 1131
30. Jennes W., Kestens L., Nixon D.F., and Shacklett B.L. Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15-the Amplispot assay. J. Immunol. Methods 270 1 (2002) 99
31. Kaul R., Rutherford J., Rowland-Jones S.L., Kimani J., Onyango J.I., Fowke K., MacDonald K., Bwayo J.J., McMichael A.J., and Plummer F.A. HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis. Aids 18 15 (2004) 2087
32. Lalvani A., Brookes R., Hambleton S., Britton W.J., Hill A.V., and McMichael A.J. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186 6 (1997) 859
33. Liu Z., Singh D.K., Sheffer D., Smith M.S., Dhillon S., Chebloune Y., Hegde R., Buch S., and Narayan O. Immunoprophylaxis against AIDS in macaques with a lentiviral DNA vaccine. Virology 351 2 (2006) 444
34. Mast E.E., Alter M.J., Holland P.V., and Purcell R.H. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E virus antibody serum panel evaluation group. Hepatology 27 3 (1998) 857
35. McCutcheon M., Wehner N., Wensky A., Kushner M., Doan S., Hsiao L., Calabresi P., Ha T., Tran T.V., Tate K.M., Winkelhake J., and Spack E.G. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J. Immunol. Methods 210 2 (1997) 149
36. Meky F.A., Stoszek S.K., Abdel-Hamid M., Selim S., Abdel-Wahab A., Mikhail N., El-Kafrawy S., El-Daly M., Abdel-Aziz F., Sharaf S., Mohamed M.K., Engle R.E., Emerson S.U., Purcell R.H., Fix A.D., and Strickland G.T. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clin. Infect. Dis. 42 5 (2006) 628
37. Meng X.J., Halbur P.G., Shapiro M.S., Govindarajan S., Bruna J.D., Mushahwar I.K., Purcell R.H., and Emerson S.U. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J. Virol. 72 12 (1998) 9714
38. Meng X.J., Wiseman B., Elvinger F., Guenette D.K., Toth T.E., Engle R.E., Emerson S.U., and Purcell R.H. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J. Clin. Microbiol. 40 1 (2002) 117
39. Naik S., Aggarwal R., Naik S.R., Dwivedi S., Talwar S., Tyagi S.K., Duhan S.D., and Coursaget P. Evidence for activation of cellular immune responses in patients with acute hepatitis E. Indian J. Gastroenterol. 21 4 (2002) 149
40. Pal R., Aggarwal R., Naik S.R., Das V., Das S., and Naik S. Immunological alterations in pregnant women with acute hepatitis E. J. Gastroenterol. Hepatol. 20 7 (2005) 1094
41. Post J.J., Pan Y., Freeman A.J., Harvey C.E., White P.A., Palladinetti P., Haber P.S., Marinos G., Levy M.H., Kaldor J.M., Dolan K.A., Ffrench R.A., Lloyd A.R., and Rawlinson W.D. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J. Infect. Dis. 189 10 (2004) 1846
42. Purcell R.H., and Emerson S.U. Animal models of hepatitis A and E. ILAR J. 42 2 (2001) 161
43. Robinson R.A., Burgess W.H., Emerson S.U., Leibowitz R.S., Sosnovtseva S.A., Tsarev S., and Purcell R.H. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr. Purif. 12 1 (1998) 75
44. Schlauder G.G., Desai S.M., Zanetti A.R., Tassopoulos N.C., and Mushahwar I.K. Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. J. Med. Virol. 57 3 (1999) 243
45. Semmo N., Barnes E., Taylor C., Kurtz J., Harcourt G., Smith N., and Klenerman P. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet 365 9456 (2005) 327
46. Shata M.T., Anthony D.D., Carlson N.L., Andrus L., Brotman B., Tricoche N., McCormack P., and Prince A. Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees. J. Viral Hepatitis 9 6 (2002) 400
47. Shata M.T., Shan M.M., Tricoche N., Talal A., Perkus M., and Prince A. Optimization of recombinant vaccinia-based ELISPOT assay. J. Immunol. Methods 283 1-2 (2003) 281
48. Shata M.T., Tricoche N., Perkus M., Tom D., Brotman B., McCormack P., Pfahler W., Lee D.H., Tobler L.H., Busch M., and Prince A.M. Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology 314 2 (2003) 601
49. Shata M.T., Pfahler W., Brotman B., Lee D.H., Tricoche N., Murthy K., and Prince A.M. Attempted therapeutic immunization in a chimpanzee chronic HBV carrier with a high viral load. J. Med. Primatol. 35 3 (2006) 165
50. Skidmore S.J., Yarbough P.O., Gabor K.A., and Reyes G.R. Hepatitis E virus: the cause of a waterbourne hepatitis outbreak. J. Med. Virol. 37 1 (1992) 58
51. Srivastava R., Aggarwal R., Jameel S., Puri P., Gupta V.K., Ramesh V.S., Bhatia S., and Naik S. Cellular immune responses in acute hepatitis e virus infection to the viral open reading frame 2 protein. Viral Immunol. 20 1 (2007) 56
52. Stoszek S., Engle R., Abdel-Hamid M., Mikhail N., Abdel-Aziz F., Medhat A., Fix A.D., Emerson S., Purcell R., and Strickland G.T. Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Transactions of the Royal Society of Tropical Medicine and Hygiene 100 2 (2006) 89
53. Sun Y., Iglesias E., Samri A., Kamkamidze G., Decoville T., Carcelain G., and Autran B. A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J. Immunol. Methods 272 1-2 (2003) 23
54. Takaki A., Wiese M., Maertens G., Depla E., Seifert U., Liebetrau A., Miller J.L., Manns M.P., and Rehermann B. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6 5 (2000) 578
55. Van Epps H.L., Terajima M., Mustonen J., Arstila T.P., Corey E.A., Vaheri A., and Ennis F.A. Long-lived memory T lymphocyte responses after hantavirus infection. J. Exp. Med. 196 5 (2002) 579
56. Yu C., Engle R.E., Bryan J.P., Emerson S.U., and Purcell R.H. Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin. Diagn. Lab. Immunol. 10 4 (2003) 579
57. Zakaria S., Fouad R., Shaker O., Zaki S., Hashem A., El-Kamary S.S., Esmat G., and Zakaria S. Changing patterns of acute viral hepatitis at a major urban referral center in Egypt. Clin. Infect. Dis. 44 4 (2007) e30
58. Zhou Y.H., Purcell R.H., and Emerson S.U. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 22 20 (2004) 2578